Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Gilead sciences, inc.    symbols : Hook    save search

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-22 (Crawled : 11:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 3.58% H: 0.0% C: -5.19%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.16% C: -0.68%

pharma business year financial results
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: -7.94% H: 8.7% C: -4.37%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 0.23% C: -3.29%

pharma business financial
HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences
Published: 2023-10-18 (Crawled : 11:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 3.19% H: 0.98% C: -1.98%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.3% C: -0.99%

hepatitis pharma vaccine publication sciences preclinical collaboration virus
HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-08-10 (Crawled : 11:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: -2.31% H: 5.56% C: 3.5%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.88% C: -0.47%

pharma business financial results
Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium
Published: 2022-06-03 (Crawled : 12:00) - biospace.com/
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 0.0% C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: -2.01% H: 0.0% C: 0.0%

preclinical hiv symposium pre-clinical vaccine
HOOKIPA Pharma to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Published: 2021-11-03 (Crawled : 13:00) - biospace.com/
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 6.8% C: 6.0%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 2.44% C: 2.21%

financial results results pharma
HOOKIPA announces publication on the benefits of its novel arenaviral immunotherapeutics in cancer in Frontiers in Oncology
Published: 2021-10-14 (Crawled : 12:00) - biospace.com/
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 2.98% H: 1.99% C: -1.81%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.86% H: 0.76% C: -0.09%

cancer
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in September
Published: 2021-09-07 (Crawled : 14:15) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M twitter stocktwits trandingview |
Finance
| | O: -0.39% H: 1.24% C: 0.1%
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 2.2% C: -2.64%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.22% H: 0.31% C: 0.15%

conference pharma
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in June
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 1.98% H: 0.78% C: -2.24%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 1.04% C: 0.43%

conference pharma
HOOKIPA Phase 1 HB-200 data show unprecedented T cell response, favorable tolerability, and preliminary efficacy as monotherapy for advanced HPV16+ cancers
Published: 2021-06-07 (Crawled : 23:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 1.13% H: 0.0% C: -20.15%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.25% C: 0.1%

phase 1 therapy cancer phase 3 phase 2 t-cell
HOOKIPA to present Phase 1 safety, tolerability and preliminary anti-tumor activity data on HB-201 and HB-202 for the treatment of advanced HPV16+ cancers at ASCO
Published: 2021-05-20 (Crawled : 12:15) - biospace.com/
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: -2.84% H: 0.54% C: -9.78%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.23% H: 1.92% C: 1.0%

treatment phase 1 cancer phase 3 phase 2
HOOKIPA Pharma to Present at Kempen Life Science Conference
Published: 2021-04-14 (Crawled : 12:15) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 2.72% C: 1.2%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.12% H: 1.85% C: 0.51%

life science conference presentation pharma
HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook
Published: 2021-03-18 (Crawled : 12:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 9.84% C: 6.32%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.24% H: 2.14% C: 0.72%

financial results results
HOOKIPA Pharma To Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 18, 2021
Published: 2021-03-09 (Crawled : 13:01) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 2.64% C: -2.23%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.17% H: 1.75% C: -1.8%

financial results results pharma
Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine
Published: 2021-03-04 (Crawled : 12:06) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.58% C: -3.75%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 2.77% C: 0.68%

cancer preclinical pre-clinical
HOOKIPA Pharma to Participate in Upcoming H.C. Wainwright Global Life Sciences Conference
Published: 2021-03-03 (Crawled : 12:03) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.84% H: 2.09% C: 0.33%
GILD | $67.07 0.06% 0.06% 8.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.85% C: -0.06%

life science pharma
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.